ADVANTOSE
Live / Applied — Statement of use — registration review complete (as of 21 Sept 2026)
What this means for you
Not registered yet, but its 19 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99557635
- Mark type
- Word mark
- Filed
- 19 Dec 2025
- Published for opposition
- 19 May 2026
- Attorney of record
- William C Wright
Goods and services
- Class 001 — Chemicals: Excipients for use in the manufacture of solid oral dose pharmaceutical and nutraceutical products
Owner
- SPI Pharma, Inc., Wilmington, DE, US
- SPI Pharma, Inc., Wilmington, DE, US
Prior registrations
Prosecution history
- 21 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Aug 2026 — USE AMENDMENT FILED
- 05 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 14 Jul 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 May 2026 — PUBLISHED FOR OPPOSITION
- 13 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Apr 2026 — ASSIGNED TO EXAMINER
- 10 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 19 Dec 2025 — NEW APPLICATION ENTERED